Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model

Yonghong Liu1, Jincheng Han1, Wen-Hao Hsu1

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Discovery
|September 30, 2024
PubMed
Abstract

Related Concept Videos